Algorithm

%%{init: {"themeVariables": { "lineWidth": "3px", "lineColor": "#000000" } }}%%
graph TD
    classDef process fill:#e3f2fd,stroke:#1565c0,stroke-width:2px,color:#1565c0
    classDef decision fill:#fff3e0,stroke:#e65100,stroke-width:2px,color:#e65100
    classDef endpoint fill:#e8f5e9,stroke:#2e7d32,stroke-width:2px,color:#2e7d32

    A([Neonate Born to COVID-19 Positive Mother])
    B[Delivery Room: Essential staff only, full PPE]
    C{Is the neonate stable?}
    D[Delayed cord clamping 60s+ & Skin-to-skin with maternal precautions]
    E[NRP Resuscitation with airborne precautions for aerosol procedures]
    F[Postnatal Care: Rooming-in at 6ft distance, exclusive breastfeeding]
    G[Testing: Perform RT-PCR at 24 hours of life]
    H{24h RT-PCR Result}
    I[Repeat RT-PCR at 48 hours or prior to discharge]
    J{Clinical Status of Neonate}
    K[Routine monitoring. Baseline labs: CBC, CRP]
    L[Evaluate: Baseline labs, empirical Abx, non-invasive respiratory support]
    M{Critically Ill / Hemodynamically Unstable?}
    N[Extended Panel, Cardiac Assessment, Manage shock. Evaluate for MIS-N]
    O[Continue supportive care. Discontinue Abx if sterile and COVID confirmed]
    P{Discharge Criteria Met?}
    Q([Discharge: Stable, oral feeding, vaccinated. Echo F/U if MIS-N])
    R([Continue Hospital Care])

    A --> B
    B --> C
    C -- Yes --> D
    C -- No --> E
    D --> F
    E --> F
    F --> G
    G --> H
    H -- Negative --> I
    H -- Positive --> J
    I --> J
    J -- Asymptomatic --> K
    J -- Symptomatic --> L
    L --> M
    M -- Yes --> N
    M -- No --> O
    K --> P
    O --> P
    N --> P
    P -- Yes --> Q
    P -- No --> R

    class A,B,D,E,F,G,I,K,L,N,O,R process
    class C,H,J,M,P decision
    class Q endpoint

Introduction And Core Principles

  • Management strictly requires balancing infection prevention against the promotion of physiological bonding and exclusive breastfeeding.
  • Vertical transmission risk remains low, approximating 3% to 8%.
  • Evidence firmly establishes that the benefits of rooming-in and breastfeeding vastly outweigh the risks of horizontal viral transmission when appropriate precautions are rigorously implemented.

Delivery Room Management Algorithm

Clinical ActionSpecific Guidelines
Staff PreparationMinimize attending personnel to essential staff only; strictly mandate full Personal Protective Equipment including N95 masks, face shields, gowns, and gloves.
Cord ClampingPerform Delayed Cord Clamping for at least 60 seconds in vigorous term and preterm infants, provided maternal stability allows.
Skin-To-Skin ContactEncourage immediate contact for stable neonates to promote thermoregulation and bonding; mandate maternal medical mask usage and rigorous hand hygiene prior to holding the infant.
Neonatal ResuscitationStrictly follow standard Neonatal Resuscitation Program guidelines. Perform aerosol-generating procedures, such as suctioning or intubation, utilizing strict airborne precautions, ideally maintaining a 6-foot distance from the mother.

Postnatal Care And Isolation Protocols

  • Routine separation of mother and neonate is actively discouraged by global and national guidelines.
  • Maintain rooming-in to facilitate breastfeeding, keeping the neonatal cot at least 2 meters (6 feet) from the maternal head when not actively feeding, utilizing physical barriers if space is restricted.
  • Exclusive breastfeeding remains strongly recommended because the SARS-CoV-2 virus is not conclusively viable in breast milk.
  • Mothers must practice rigorous respiratory hygiene, wearing a triple-layer mask, and wash hands with soap and water for at least 20 seconds before and after neonatal contact.
  • Provide a healthy, vaccinated, COVID-negative caregiver or utilize expressed breast milk if the mother is too ill to provide direct care.

Neonatal Testing Strategy

Testing ParameterProtocol Details
Timing And MethodPerform nucleic acid amplification testing via RT-PCR at 24 hours of life. Repeat testing at 48 hours or prior to discharge if the initial test is negative.
Sample CollectionUtilize nasopharyngeal or oropharyngeal swabs.
Positive <24 HoursStrongly suggests intrauterine or intrapartum viral transmission.
Positive >48 HoursStrongly suggests horizontal postnatal transmission from the mother or the environment.

Clinical Evaluation And Monitoring

Clinical Manifestations

  • The vast majority exceeding 90% of exposed neonates remain completely asymptomatic.
  • Symptomatic neonates frequently mimic bacterial sepsis or respiratory distress syndrome.
  • Respiratory signs encompass tachypnea, grunting, nasal flaring, and oxygen desaturations.
  • Systemic and neurological signs include temperature instability, lethargy, hypotonia, and rare seizures.
  • Gastrointestinal signs feature feeding intolerance, vomiting, and diarrhea.

Laboratory Evaluation Algorithm

Evaluation TierRecommended Investigations
Baseline Screening• Complete blood count to identify lymphopenia or leukocytosis;
• C-reactive protein evaluation.
Extended PanelFor critically ill infants, evaluate cytokine storm and coagulopathy utilizing
• D-dimer
• Ferritin
• LDH
• Procalcitonin
• Liver Function Tests.
Cardiac AssessmentIn the presence of hemodynamic instability to exclude myocardial dysfunction, evaluate
• Troponin-I
• NT-proBNP

Management Of Symptomatic Neonates

Supportive And Pharmacological Therapy

  • Implement non-invasive respiratory support utilizing CPAP or HFNC as the first-line intervention for respiratory distress.
  • Mandate the use of viral filters on expiratory limbs of respiratory circuits to protect healthcare personnel.
  • Restrict intubation and mechanical ventilation strictly for severe respiratory failure or shock.
  • Manage shock with careful fluid resuscitation and initiate inotropes, such as epinephrine or dobutamine, for myocardial dysfunction or hypotension.
  • Initiate empirical antibiotics pending blood culture results due to frequent clinical overlap with bacterial sepsis; discontinue antibiotics if cultures return sterile and COVID-19 is confirmed.
  • Corticosteroids and prophylactic anticoagulation are not routinely recommended for acute neonatal COVID-19 unless specific criteria for severe refractory shock or confirmed thrombotic events are met.

Multisystem Inflammatory Syndrome In Neonates (MIS-N)

  • MIS-N constitutes a distinct hyperinflammatory condition occurring secondary to the transplacental transfer of maternal SARS-CoV-2 IgG antibodies.
  • Clinical presentation features profound cardiac dysfunction, arrhythmias, coronary artery dilation, and Persistent Pulmonary Hypertension of the Newborn.
  • Fever is notably absent in the majority of documented cases.
  • Severe cases mandate immediate immunomodulation utilizing Intravenous Immunoglobulin administered at 2 g/kg alongside Methylprednisolone.

Discharge Criteria And Follow-Up

  • Authorize discharge when the neonate demonstrates physiological stability, adequate oral feeding, and consistent weight gain.
  • Administer routine birth immunizations, including BCG, OPV, and Hepatitis B vaccines, strictly prior to discharge.
  • Counsel parents comprehensively regarding danger signs, including fast breathing, chest indrawing, lethargy, and temperature instability.
  • Mandate follow-up echocardiography at 2 to 6 weeks for infants recovering from severe neonatal COVID-19 or MIS-N to assess coronary arteries and ventricular function.